Cansino OTC Stock Analysis


USD 5.45  0.06  1.09%   

The big decline in price over the last few months for Cansino Biologics could raise concerns from shareholders as the firm is trading at a share price of 5.45 on slow start in volume. The company management teams failed to add value to investors and position the firm supply of money to exploit market volatility in September. However, diversifying your holdings with Cansino Biologics or similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 4.09. This high volatility is attributed to the latest market swings and not-so-good earnings reports for some of the Cansino Biologics partners.
Continue to Trending Equities.
The Cansino Biologics otc stock analysis report makes it easy to digest most publicly released information about Cansino Biologics and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Cansino OTC Stock analysis module also helps to analyze the Cansino Biologics price relationship with some important fundamental indicators such as market cap and management efficiency.

Cansino OTC Stock Analysis Notes

About 27.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.18. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cansino Biologics last dividend was issued on the 13th of July 2022. CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the Peoples Republic of China. CanSino Biologics Inc. was incorporated in 2009 and is headquartered in Tianjin, the Peoples Republic of China. Cansino Biologics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1946 people.The quote for Cansino Biologics is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. For more info on Cansino Biologics please contact the company at 400 922 2099 or go to

Cansino Biologics Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more otcs at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Cansino Biologics' investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Cansino Biologics or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Cansino Biologics generated a negative expected return over the last 90 days
Cansino Biologics has high historical volatility and very poor performance
Cansino Biologics has high likelihood to experience some financial distress in the next 2 years
About 27.0% of the company shares are held by company insiders
On 31st of August 2022 Cansino Biologics paid $ 0.1194 per share dividend to its current shareholders
Latest headline from WHO chief reiterates belief that COVID-19 pandemic end near, says work still needed - Seeking Alpha

Cansino Market Capitalization

The company currently falls under 'Mid-Cap' category with current market capitalization of 1.83 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cansino Biologics's market, we take the total number of its shares issued and multiply it by Cansino Biologics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Cansino Profitablity

Cansino Biologics' profitability indicators refer to fundamental financial ratios that showcase Cansino Biologics' ability to generate income relative to its revenue or operating costs. If, let's say, Cansino Biologics is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Cansino Biologics' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Cansino Biologics' profitability requires more research than a typical breakdown of Cansino Biologics' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 47.32 %, which can signify that it executes well on its competitive strategies and has good control over its expenditures. This is very large. Similarly, it shows Operating Margin (OM) of 44.91 %, which suggests for every 100 dollars of sales, it generated a net operating income of 0.45.

Management Efficiency

The entity has return on total asset (ROA) of 12.5 % which means that it generated profit of $12.5 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on equity (ROE) of 27.73 %, meaning that it generated $27.73 on every $100 dollars invested by stockholders. Cansino Biologics management efficiency ratios could be used to measure how well cansino biologics manages its routine affairs as well as how well it operates its assets and liabilities.

Technical Drivers

As of the 1st of October, Cansino Biologics shows the mean deviation of 2.33, and Risk Adjusted Performance of (0.27). Cansino Biologics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed nineteen technical drivers for Cansino Biologics, which can be compared to its rivals. Please confirm Cansino Biologics maximum drawdown, and the relationship between the information ratio and downside variance to decide if Cansino Biologics is priced correctly, providing market reflects its regular price of 5.45 per share. Given that Cansino Biologics has jensen alpha of (0.92), we suggest you to validate Cansino Biologics's prevailing market performance to make sure the company can sustain itself at a future point.

Cansino Biologics Price Movement Analysis

The output start index for this execution was thirty with a total number of output elements of thirty-one. The Moving Average is predictive technique used to analyze Cansino Biologics price data points by creating a series of averages of different subsets of Cansino Biologics entire price series.

Cansino Biologics Technical and Predictive Indicators

Cansino Biologics Forecast Models

Cansino Biologics time-series forecasting models is one of many Cansino Biologics' otc stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cansino Biologics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Cansino OTC Stock Analysis

OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Cansino Biologics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cansino shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual OTC such as Cansino Biologics. By using and applying Cansino OTC Stock analysis, traders can create a robust methodology for identifying Cansino entry and exit points for their positions.
CanSino Biologics Inc. develops, manufactures, and commercializes vaccines in the Peoples Republic of China. CanSino Biologics Inc. was incorporated in 2009 and is headquartered in Tianjin, the Peoples Republic of China. Cansino Biologics operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 1946 people.

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Cansino Biologics to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Crypto Correlations Now


Crypto Correlations

Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
All  Next Launch Module
Continue to Trending Equities. Note that the Cansino Biologics information on this page should be used as a complementary analysis to other Cansino Biologics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Complementary Tools for Cansino OTC Stock analysis

When running Cansino Biologics price analysis, check to measure Cansino Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cansino Biologics is operating at the current time. Most of Cansino Biologics' value examination focuses on studying past and present price action to predict the probability of Cansino Biologics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cansino Biologics' price. Additionally, you may evaluate how the addition of Cansino Biologics to your portfolios can decrease your overall portfolio volatility.
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Transaction History
View history of all your transactions and understand their impact on performance
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Is Cansino Biologics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cansino Biologics. If investors know Cansino will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cansino Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cansino Biologics is measured differently than its book value, which is the value of Cansino that is recorded on the company's balance sheet. Investors also form their own opinion of Cansino Biologics' value that differs from its market value or its book value, called intrinsic value, which is Cansino Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cansino Biologics' market value can be influenced by many factors that don't directly affect Cansino Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cansino Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine Cansino Biologics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cansino Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.